Apotex recalls

14 official recalls and safety alerts involving Apotex since 2022-05, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Apotex or the relevant agency.

  1. 2026-10-07
  2. US
  3. 2026-09-02
  4. US
    Drugs & medicalClass II

    Apotex Corp. recalls Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada…

    Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

    FDA · DrugApotex Corp.US Nationwide.Official notice →
  5. 2026-04-22
  6. US
    Drugs & medicalClass II

    Apotex Corp. recalls Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg…

    Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

    FDA · DrugApotex Corp.U.S.A. NationwideOfficial notice →
  7. 2026-03-25
  8. US
  9. 2025-10-08
  10. US
    Drugs & medicalClass II

    Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc.,…

    Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

    FDA · DrugApotex Corp.Nationwide in the USOfficial notice →
  11. 2025-07-02
  12. US
  13. 2025-06-11
  14. US
    Drugs & medicalClass II

    Apotex Corp. recalls Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured…

    Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

    FDA · DrugApotex Corp.US Nationwide.Official notice →
  15. 2024-02-28
  16. US
    Drugs & medicalClass II

    Apotex Corp. recalls Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario…

    CGMP Deviations: potential presence of Burkholderia cepacia complex

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →
  17. 2023-12-06
  18. US
    Drugs & medicalClass II

    Apotex Corp. recalls Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-count bottle, NDC#:60505-0084-2,…

    Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

    FDA · DrugApotex Corp.NationwideOfficial notice →
  19. 2023-05-17
  20. US
    Drugs & medicalClass II

    Apotex Corp. recalls Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Calcitonin Salmon Units/spray, 3.7 mL…

    Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.

    FDA · DrugApotex Corp.Nationwide throughout the United StatesOfficial notice →
  21. 2023-03-15
  22. US
    Drugs & medicalClass II

    Apotex Corp. recalls Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1, UPC 3 60505 05641 5; b) 10…

    Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →
  23. 2023-01-04
  24. US
    Drugs & medicalClass III

    Apotex Corp. recalls Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp.…

    Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

    FDA · DrugApotex Corp.USA NationwideOfficial notice →
  25. 2022-07-27
  26. US
    Drugs & medicalClass II

    Apotex Corp. recalls Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC…

    Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

    FDA · DrugApotex Corp.USA NationwideOfficial notice →
  27. 2022-05-25
  28. US
    Drugs & medicalClass III

    Apotex Corp. recalls Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for:…

    Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →